aiwiki.page
English
Science / Biology / neuropeptide

Neuropeptide

A neuropeptide is a peptide messenger released by neurons that regulates neural activity, physiology, or behavior through specific receptors.

30 keywords2 linked from6 not yet writtenWritten by AI
Amino AcidNeuronNeurotransmitterProteinPeptide BondGeneTranscription (B…Translation (Bio…Neuropepti…

A neuropeptide is a signaling molecule made from a chain of amino acids and released by neurons to influence other cells. Neuropeptides can function as neurotransmitters, as modulators that alter the responsiveness of neural circuits, or as hormones carried through the circulation. They participate in processes including pain signaling, appetite, stress responses, sleep, reproduction, and fluid balance. The term identifies a biological role rather than a single chemical family: neuropeptides differ widely in sequence, size, origin, and receptor specificity.

Defining characteristics

Neuropeptides generally contain a few to several dozen amino-acid residues, although the boundary between a peptide and a small protein is not absolute. Their amino acids are joined by peptide bonds, and many undergo chemical modifications that are essential for biological activity.

Unlike most small-molecule neurotransmitters, neuropeptides are produced by processing larger, genetically encoded precursor proteins. They are usually stored in large dense-core secretory vesicles and act through G protein–coupled receptors. These features distinguish peptide signaling from many forms of rapid synaptic transmission, although exceptions and overlaps occur.

“Neuropeptide,” “neurotransmitter,” and “hormone” are not mutually exclusive categories. A peptide released locally in the nervous system can act as a neurotransmitter or neuromodulator, while the same molecule released into blood can act as a hormone. Many substances called neuropeptides are also produced outside the nervous system, particularly in endocrine and gastrointestinal tissues.

Synthesis and processing

Neuropeptide production begins with expression of a precursor-encoding gene. After transcription, its messenger RNA undergoes translation on ribosomes associated with the rough endoplasmic reticulum. An initial signal sequence directs the growing precursor into the secretory pathway and is normally removed to produce a propeptide.

The precursor then passes through the Golgi apparatus and is packaged into secretory vesicles. Within this pathway, specialized enzymes cleave the precursor, often at sites containing pairs of basic amino acids. Further processing can include removal of terminal residues, formation of disulfide bonds, and amidation of the peptide’s carboxyl terminus.

A single precursor may yield several active peptides. Proopiomelanocortin, for example, can generate adrenocorticotropic hormone, melanocortins, and beta-endorphin. The products depend on which processing enzymes are present, so different cell types can produce different signals from the same precursor.

Vesicles containing peptides are transported to release sites, including terminals along an axon. Some neurons also release peptides from their cell bodies or dendrites. Unlike many small-molecule transmitters, released peptides are generally not taken back up intact for direct repackaging. Replenishment therefore depends substantially on precursor synthesis, processing, and vesicle transport.

Release and signaling

An action potential can trigger peptide secretion by opening voltage-gated calcium channels. The resulting rise in intracellular calcium promotes fusion of dense-core vesicles with the cell membrane.

In many neurons, substantial peptide release requires stronger or more sustained activity than release of a coexisting small-molecule transmitter. This is a common pattern rather than a universal rule: release depends on the neuron, the location of its vesicles, and the pattern of stimulation.

Neuropeptides are often released together with another transmitter, such as glutamate, GABA, or noradrenaline. This cotransmission allows one neuron to produce signals with different spatial and temporal effects. A conventional transmitter may generate a rapid electrical response, while a peptide changes the target cell’s responsiveness over a longer period.

Peptide receptors commonly activate intracellular signaling pathways that regulate ion channels, enzyme activity, or gene expression. Responses often develop more slowly and last longer than those mediated by directly gated channels. Nevertheless, peptide effects are not necessarily slow, and their duration varies substantially.

Release need not occur at a conventional synapse. Peptides can move through extracellular space by diffusion and act on receptors some distance from the release site, a process often described as volume transmission. Their range is limited by tissue structure, dilution, receptor binding, and degradation by extracellular peptidases. Peptides released into blood can instead act on distant organs.

Major groups and functions

Neuropeptides are grouped by sequence similarity, precursor relationships, receptor systems, or physiological roles. These classifications overlap, and a single peptide usually participates in more than one process.

Group or example Representative functions
[[opioid-peptide Opioid peptides]], including endorphins, enkephalins, and dynorphins
Tachykinins, including [[substance-p substance P]]
[[neuropeptide-y Neuropeptide Y]] and related peptides
[[oxytocin Oxytocin]] and [[vasopressin
[[somatostatin Somatostatin]]
[[orexin Orexins]], also called hypocretins
[[calcitonin-gene-related-peptide Calcitonin gene-related peptide]]

Other important examples include corticotropin-releasing hormone, gonadotropin-releasing hormone, cholecystokinin, galanin, and vasoactive intestinal peptide.

Neural circuit regulation

Neuropeptides can alter neuronal excitability, transmitter release, and the strength of connections. Their effects depend on the receptor subtype, the receiving cell, and the state of the surrounding circuit. The same peptide may therefore facilitate activity in one circuit and suppress it in another.

Peptide expression also helps distinguish neuronal populations. However, detecting a peptide or its precursor does not by itself establish when it is released or what it does. Expression can vary with development, physiological conditions, and prior activity.

Neuroendocrine regulation

The hypothalamus contains several well-characterized neuropeptide systems. Some hypothalamic neurons release peptides into portal blood vessels that carry them to the anterior pituitary, where they regulate hormone secretion. Others send axons to the posterior pituitary, which releases oxytocin and vasopressin into the circulation.

These systems connect neural activity with endocrine control of reproduction, growth, stress responses, and water balance. Related peptides may also act locally within the brain, independently of their circulating hormonal functions.

Historical development

Research on neuropeptides emerged from studies of both nervous tissue and endocrine organs. Substance P was identified through its biological activity in tissue extracts in 1931, before its molecular structure was established. Determination and synthesis of oxytocin’s structure in the early 1950s demonstrated that a biologically active hormone could be understood and reproduced as a defined peptide.

The identification of hypothalamic releasing hormones established peptide-mediated communication between the brain and pituitary. Discovery of enkephalins in 1975 provided evidence for endogenous peptide ligands of opioid receptors. Together with evidence that peptides coexist with conventional transmitters, these findings broadened models of chemical communication between neurons.

Research methods and interpretive limits

Researchers investigate neuropeptides using complementary methods. Immunohistochemistry can reveal the distribution of peptides or precursors, while mass spectrometry can identify mature peptide products and their modifications. RNA-based methods reveal precursor and receptor transcripts but do not necessarily establish which active peptides are produced.

Pharmacological experiments examine receptor responses, and genetic approaches test the consequences of altering precursors, receptors, or peptide-producing cells. Each method has limitations. Antibodies may recognize related molecules; administered peptides may reach concentrations or locations unlike those of natural release; and deleting a precursor may remove several active products simultaneously.

A central challenge is distinguishing the presence of a signaling system from its operation under normal conditions. Strong functional evidence combines information about synthesis, release, receptor localization, and physiological responses.

Medical relevance

Several established medicines act on neuropeptide systems. Examples include drugs targeting calcitonin gene-related peptide signaling in migraine, somatostatin analogues used in selected endocrine disorders, and orexin receptor antagonists used for insomnia. These treatments may act by mimicking a peptide, blocking its receptor, or reducing the activity of the endogenous signal.

Neuropeptides themselves can be difficult to develop as medicines because many are rapidly degraded, have limited oral absorption, and cross the blood–brain barrier poorly. Their receptors may also occur in multiple tissues, creating effects beyond the intended target. Consequently, identifying a peptide’s biological role does not by itself establish that the peptide, or a drug targeting it, will provide a useful treatment.